186328
Collaborating to Improve Birth Outcomes in New Jersey
Tuesday, October 28, 2008: 1:15 PM
Sheree Neese-Todd, MA
,
Center for Health Care Strategies, Inc., Hamilton, NJ
Judy Donlen, RN, DNSc, JD
,
Southern NJ Perinatal Cooperative, Pennsauken, NJ
In 2006, with support from the Center for Health Care Strategies, Inc. (CHCS) the five Medicaid managed care health plans in New Jersey collaborated to identify high-risk pregnancies and improve birth outcomes in three cities. One year later, key accomplishments include a uniform prenatal risk assessment form (PRA), a central data repository for prenatal care data, an expedited Medicaid enrollment process for pregnant women, and solid plans to take the program statewide A broad coalition contributed to this quality improvement effort including Family Health Initiatives (FHI) which led the effort to develop and manage a central data repository, community stakeholders and providers, and multiple state agencies and departments. The collaborative workgroup implemented standardized prenatal risk assessment within a quality improvement framework that focused upon improving clinical and administrative practices at the level of the health plan and community providers. Discussion will include reports of screening and outcome data and strategies to use these data to inform policy changes.
Learning Objectives: Participants will be able to:
Describe the CHCS collaborative framework for quality improvement.
Identify opportunities for interagency collaboration to improve health care and outcomes for pregnant women and infants.
Describe how risk screening data can be used to improve clinical management and birth outcomes.
Discuss the challenges of developing and employing a standardized risk assessment form.
Keywords: Policy/Policy Development, Perinatal Outcomes
Presenting author's disclosure statement:Qualified on the content I am responsible for because: I represent the agency responsible for data management and analysis.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.
|